Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

usual

usual is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 2
Pipeline programs 18
News articles 0
Drug details — usual
Class
—
Route
—
Patents
2
Programs
18
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

usual is an FDA-listed pharmaceutical active ingredient.

Key facts

INN usual

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 2021/3336 Phase 3 · George Institute for · Maintenance treatment in metastatic non-squamous lung cancer
  2. Abiraterone - Usual Phase 3 · Lxo Ireland Designated · Prostate Cancer
  3. Alectinib - Usual Phase 3 · Lxo Ireland Designated · ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
  4. ETOPOSIDE - Usual Phase 3 · Lxo Ireland Designated · Small Cell Lung Cancer
  5. Methadone Treatment-As-Usual Phase 3 · BRIGHT MINDS BIOSCIENCES · Opioid Use
  6. Raloxifene - Usual Phase 3 · Lxo Ireland Designated · Breast Cancer
  7. Topotecan - usual Phase 3 · Lxo Ireland Designated · SCLC
  8. Treatment as Usual (TAU) Phase 3 · BRIGHT MINDS BIOSCIENCES · Drug Addiction

Related patents

Browse patents

  1. US 11976329

    Methods and systems for detecting usual interstitial pneumonia

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10046057

    Methods for arranging and packing nucleic acids for unusual resistance to nucleases and targeted delivery for gene therapy

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is usual?

usual is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.